Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
14:26 | MRI and Astellas to support Japanese drug-discovery startups | ||
Fr | Health Canada authorises Roche's PiaSky for PNH | ||
Do | Salipro Biotech collaborates with Daewoong for new therapies development | ||
Mi | Monte Rosa Therapeutics receives FDA clearance for MRT-8102 IND | ||
Di | Neowise and BeOne Medicines sign agreement for cell therapy development | ||
09.06. | Italfarmaco's Duvyzat gains EC conditional approval for DMD treatment | ||
06.06. | Alvotech and Dr. Reddy's partner for Keytruda biosimilar | ||
05.06. | FDA grants breakthrough therapy status for Cellectar's iopofosine I 131 | ||
04.06. | Camurus and Eli Lilly collaborate on long-acting incretin products | ||
03.06. | Zealand Pharma submits glepaglutide MAA for short bowel syndrome | ||
02.06. | Mabwell's Mailisheng receives NMPA marketing approval | ||
30.05. | US FDA approves Alcon's Tryptyr ophthalmic solution for Dry Eye Disease | ||
29.05. | Archeus Technologies partners with WARF to advance ART-101 for prostate cancer | ||
28.05. | GRIN Therapeutics and Angelini Pharma collaborate on radiprodil development | ||
27.05. | Henlius receives ODD for HLX22 from European Commission | ||
26.05. | Orion partners with Shilpa Biocare for recombinant human albumin in Europe | ||
23.05. | Genentech gains FDA approval for diabetic retinopathy treatment | ||
22.05. | Juvenescence secures $76m funding to advance therapeutic pipeline | ||
21.05. | Mirai Bio and Thermo Fisher to advance genetic medicine development | ||
20.05. | FDA grants fast track status to Zai Lab's lung cancer treatment | ||
19.05. | Canadian research initiative secures grant for paediatric brain cancer | ||
16.05. | FDA grants RMAT to BrainChild Bio's CAR T-cell therapy for DIPG | ||
15.05. | AbbVie and ADARx to develop siRNA therapeutics for multiple disease areas | ||
14.05. | FDA to review Regenxbio's gene therapy BLA for Hunter syndrome | ||
13.05. | InnoCare's Mesutoclax obtains breakthrough therapy designation in China |